Clinical Trial

Histological Analysis of CelluJuve® Injections in the Brachium

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2025 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Single-center, exploratory study assessing the safety and histological presentation of CelluJuve® injected into the brachium of healthy volunteers
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-08.
Trial Details
NCT Number NCT06930209
Lead Sponsor Spiderwort Biotechnologies Inc.
Collaborators: ethica Clinical Research Inc.
Conditions Healthy Male and Female Subjects
Enrollment 10 participants
Start Date 2025-03-28
Primary Completion 2025-07-15 (estimated)
Study Completion 2027-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-20